Related Experiment Videos
Negotiating the maze of biotech "tool patents"
1Celtrix Pharmaceuticals, Santa Clara, CA 95054-1815, USA. desmond@celtrix.com
Nature Biotechnology
|December 16, 1998
Abstract:
Circumventing existing patents may be a shortcut to getting your recombinant protein to market.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Myocarditis post-SARS-CoV-2 vaccination: a systematic review.
QJM : monthly journal of the Association of Physicians·2022
Hyperintense Optic Nerve due to Diffusion Restriction: Diffusion-Weighted Imaging in Traumatic Optic Neuropathy.
AJNR. American journal of neuroradiology·2015
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).
Journal of the National Cancer Institute·2001
Anabolic effects of rhIGF-I/IGFBP-3 in vivo are influenced by thyroid status.
European journal of clinical investigation·2001
Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin-like growth factor binding protein-3.
Journal of cellular biochemistry·2000
Mechanochemically Programmed, Oligomer-Selective Amyloid Assembly via Axial Rotation.
Small (Weinheim an der Bergstrasse, Germany)·2026
[Construction and practice of a talent training model for synthetic biology].
Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2026
Design of biosurfactant proteins with pH-sensitive reversible surface-active property and their excellent foam and emulsion stability.
Food research international (Ottawa, Ont.)·2026
Chemically Induced Dimerization Systems: From FKBP/FRB Engineering to Expanded Biological Applications.
Biochemistry. Biokhimiia·2026